Researcher
Eric Florence
Affiliations
- HIV/STI Clinic (Research unit)
Member
From1 Oct 2006 → 30 Sep 2022 - HIV/STI Clinic (Research unit)
Member
From30 Sep 2006 → 16 Apr 2015
Projects
1 - 9 of 9
- Contemporary challenges in Human Immunodeficiency Virus Pre-Exposure-Prophylaxis care in BelgiumFrom15 Nov 2022 → Today
- PReventing the Emergence of untreatable STIs via radical PreventionFrom1 Jan 2021 → Today
- Ontwikkeling en evaluatie van een gecomputeriseerde interventie voor chemsex ondersteuningFrom19 Nov 2020 → 31 Dec 2021
- Chemified: pilot testing of a mobile application for chemsexcare and supportFrom20 Oct 2020 → 20 Oct 2021
- Hepatitis C virus direct acting antiviral (DAA) treatment success and its impact on transmission dynamics in HIV/HCV co-infected MSMFrom1 Jan 2017 → 31 Dec 2022
- Evaluating mHealth technology in HIV to improve Empowerment and healthcare utilisation: Research and innovation to Generate Evidence for personalised careFrom1 May 2015 → 30 Sep 2020
- Analytical treatment interruption in HIV positive patients with low viral reservoir to evaluate the potential of a functional cureFrom1 Nov 2014 → 31 Oct 2018
- Hepatitis C treatment for HIV patients in resource-poor countries: is a public health approach possibleFrom1 Jul 2014 → 31 Dec 2019
- Operational knowledge to improve HIV early diagnosis and treatment among vulnerable groups in EuropeFrom1 Apr 2014 → 30 Sep 2017
Publications
31 - 40 of 152
- Uptake of oral pre-exposure prophylaxis for HIV infection among men who have sex with men and transgender: lessons learned during the SARS-CoV-2 pandemic from the first PrEP project in Myanmar(2021)
Authors: N. N. Tun, Tinne Gils, Lut Lynen, M. Min, M. Y. Aung, F Smithuis, K. Gustafson, Eric Florence
Pages: 37-37 - The population-level effect of screening for M. genitalium on antimicrobial resistance: a quasi-experimental study(2021)
Authors: Chris Kenyon, Irith De Baetselier, Thibaut Vanbaelen, Jozefien Buyze, E Florence
Pages: 629-634 - Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV(2021)
Authors: Ana González-Cordón, Lambert Assoumou, Graeme Moyle, Laura Waters, Margaret Johnson, Pere Domingo, Julie Fox, Hans-Jürgen Stellbrink, Giovanni Guaraldi, Mar Masia, et al.
Pages: 2380-2393 - The impact of physical restriction measures imposed during the two waves of COVID-19 on chlamydia and gonorrhea diagnoses in Belgium: results of an sexually transmitted infection clinic(2021)
Authors: Irith De Baetselier, Ludwig Apers, Tom Platteau, Jozefien Buyze, Eric Florence, Chris Kenyon, Dorien Van Den Bossche
Pages: 998-1003 - Quality of life in people living with HIV: an exploratory cross-sectional survey in Belgium(2021)
Authors: Gert Scheerder, Sandra Van den Eynde, Patrick Reyntiens, Ria Koeck, Jessika Deblonde, Charles Ddungu, Eric Florence, Christina Joosten, Eric Van Wijngaerden, Alexis Dewaele
Pages: 249-264 - Incidence and risk factors for suicide, violent/accidental deaths, and substance abuse deaths in persons living with HIV(2021)
Authors: E. Tusch, L. Peters, O. Fursa, L. Ryom, L. Oestergaard, Eric Florence, S. Edwards, Christopher J Hoffmann, H Sambatakou, P. Reiss, et al.
Pages: 236-237 - Clinical characteristics and outcomes of COVID-19 in people living with HIV in Belgium: a multicenter, retrospective cohort(2021)
Authors: Rakan Nasreddine, E Florence, Michel MOUTSCHEN, Jean Cyr Yombi, Jean-Christophe Goffard, Inge Derdelinckx, Patrick Lacor, Linos Vandekerckhove, Peter Messiaen, Stefaan Vandecasteele, et al.
Pages: 2971-2978 - Antibacterial mouthwash to prevent sexually transmitted infections in men who have sex with men taking HIV pre-exposure prophylaxis (PReGo): a randomised, placebo-controlled, crossover trial(2021)
Authors: Achilleas Tsoumanis, Anke Rotsaert, Beatrijs Vuylsteke, Dorien Van Den Bossche, Elke Paeleman, Irith De Baetselier, Isabel Brosius, Jolein Laumen, Jozefien Buyze, Kristien Wouters, et al.
Pages: 657-667 - Cabotegravir and Rilpivirine Implementation Study in European Locations (CARISEL): examining health care staff attitudes during a hybrid III implementation-effectiveness trial implementing cabotegravir plus rilpivirine long-acting injectable (CAB plus RPV LA) for people living with HIV (PLHIV)(2021)
Authors: C. Gutner, S. Dakhia, Mandev S. Gill, M. Pascual-Bernaldez, Brenda Y. Hernandez, A. Rami, J. Portilla, T. Lutz, Marc van der Valk, Eric Florence, et al.
Pages: 114-115 - Did pre-exposure prophylaxis roll-out influence the epidemic of rectal lymphogranuloma venereum in Belgium? Results from the national surveillance system(2021)
Authors: Irith De Baetselier, Achilleas Tsoumanis, E Florence, Wim Vanden Berghe, Tania Crucitti, Dorien Van den Bossche, Chris Kenyon
Pages: e1-e5